Aster DM Quality Care Limited
NSE: ASTERDM · Hospital
Snapshot
Unlock Aster DM Quality Care Limited's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Aster DM Healthcare is a diversified healthcare provider operating hospitals, clinics, and retail pharmacies across India and international markets. The company delivers a comprehensive range of primary to quaternary care services under the Aster, Medcare, and Access brands.
Business Model
The company generates revenue through a multi-vertical healthcare delivery model encompassing hospital services, diagnostic laboratories, and retail pharmacy operations. It leverages a large network of facilities to provide integrated patient care and digital health solutions.
- Hospitals:29
- Clinics:120
- Retail Pharmacies:371
- Labs:114
Growth Outlook
Growth is driven by the expansion of its hospital and diagnostic network, alongside the scaling of digital health initiatives. The company continues to focus on strengthening its presence in both domestic and international markets.
Key Risks
- Regulatory Risk. Changes in healthcare policies, pricing caps on medical services, or pharmaceutical regulations in India and the UAE could impact profit margins.
- Operational Complexity. Managing a vast network of hospitals, clinics, and pharmacies across multiple geographies requires significant capital expenditure and operational oversight.
- Talent Retention. The healthcare sector faces intense competition for skilled medical professionals, which may lead to increased wage costs and recruitment challenges.
- Geopolitical Risk. Operating across international borders exposes the company to currency fluctuations and geopolitical instability in the Middle East and other regions.
Start your research today
Unlock AI insights, financials, peers and live data on Aster DM Quality Care Limited and 5,000+ companies — free.
Key Metrics
REVENUE
₹4,876 Cr
TTM · consolidated
NET PROFIT
₹363 Cr
TTM · consolidated
EPS
₹6.18
TTM · consolidated
RETURN ON EQUITY
9.1%
TTM · consolidated
RETURN ON CAPITAL EMPLOYED
10.5%
TTM · consolidated
P/E
127.1x
Q1 FY27 · consolidated
EV/EBITDA
63.4x
Q1 FY27 · consolidated
EBITDA MARGIN
22.3%
TTM · consolidated
NET PROFIT MARGIN
2.2%
Q1 FY27 · consolidated
DEBT TO EQUITY
0.1x
Q1 FY27 · consolidated
Peers · Hospital
| Company | Mkt Cap | P/E | EV/EBITDA | Rev Gr YoY | EBITDA Mgn | ROE | ROCE | 1Y Return |
|---|---|---|---|---|---|---|---|---|
Aster DM Quality Care LimitedASTERDM | ₹68,492 Cr | 127.14 | 63.42 | 15.7% | 22.3% | 9.1% | 10.5% | +23.6% |
Max Healthcare Institute Ltd.MAXHEALTH | ₹95,845 Cr | 65.70 | 39.70 | 16.0% | 28.5% | 14.5% | 13.8% | -15.1% |
Manipal Health Enterprises LimitedMANIPALHOS | ₹95,391 Cr | — | — | — | 25.0% | — | — | — |
Fortis Healthcare Ltd.FORTIS | ₹68,324 Cr | 65.20 | 32.45 | 17.5% | 22.9% | 11.4% | 13.0% | -4.7% |
Global Health Ltd.MEDANTA | ₹39,518 Cr | 71.00 | 37.60 | 21.3% | 23.0% | 15.0% | 17.2% | +3.4% |
Narayana Hrudayalaya Ltd.NH | ₹37,980 Cr | 46.25 | 22.61 | 57.8% | 20.5% | 20.0% | 15.4% | +1.1% |
As of Q1 FY27
Financials
Aster DM Quality Care Limited
NSE: ASTERDM · Hospital
Snapshot
Unlock Aster DM Quality Care Limited's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Aster DM Healthcare is a diversified healthcare provider operating hospitals, clinics, and retail pharmacies across India and international markets. The company delivers a comprehensive range of primary to quaternary care services under the Aster, Medcare, and Access brands.
Business Model
The company generates revenue through a multi-vertical healthcare delivery model encompassing hospital services, diagnostic laboratories, and retail pharmacy operations. It leverages a large network of facilities to provide integrated patient care and digital health solutions.
- Hospitals:29
- Clinics:120
- Retail Pharmacies:371
- Labs:114
Growth Outlook
Growth is driven by the expansion of its hospital and diagnostic network, alongside the scaling of digital health initiatives. The company continues to focus on strengthening its presence in both domestic and international markets.
Key Risks
- Regulatory Risk. Changes in healthcare policies, pricing caps on medical services, or pharmaceutical regulations in India and the UAE could impact profit margins.
- Operational Complexity. Managing a vast network of hospitals, clinics, and pharmacies across multiple geographies requires significant capital expenditure and operational oversight.
- Talent Retention. The healthcare sector faces intense competition for skilled medical professionals, which may lead to increased wage costs and recruitment challenges.
- Geopolitical Risk. Operating across international borders exposes the company to currency fluctuations and geopolitical instability in the Middle East and other regions.
Start your research today
Unlock AI insights, financials, peers and live data on Aster DM Quality Care Limited and 5,000+ companies — free.
Key Metrics
REVENUE
₹4,876 Cr
TTM · consolidated
NET PROFIT
₹363 Cr
TTM · consolidated
EPS
₹6.18
TTM · consolidated
RETURN ON EQUITY
9.1%
TTM · consolidated
RETURN ON CAPITAL EMPLOYED
10.5%
TTM · consolidated
P/E
127.1x
Q1 FY27 · consolidated
EV/EBITDA
63.4x
Q1 FY27 · consolidated
EBITDA MARGIN
22.3%
TTM · consolidated
NET PROFIT MARGIN
2.2%
Q1 FY27 · consolidated
DEBT TO EQUITY
0.1x
Q1 FY27 · consolidated
Peers · Hospital
As of Q1 FY27